Get the Stockscreener App
74.81
1.19%
0.88
Edwards Lifesciences Corp stock is traded at $74.81, with a volume of 13.12M.
It is up +1.19% in the last 24 hours and up +7.58% over the past month.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
See More
Previous Close:
$73.93
Open:
$73.3
24h Volume:
13.12M
Relative Volume:
2.44
Market Cap:
$44.12B
Revenue:
$6.60B
Net Income/Loss:
$4.16B
P/E Ratio:
31.97
EPS:
2.34
Net Cash Flow:
$490.10M
1W Performance:
+2.03%
1M Performance:
+7.58%
6M Performance:
-15.79%
1Y Performance:
+0.93%
1-Day Range:
$72.97
$75.27
1-Week Range:
$72.29
$75.27
52-Week Range:
$58.93
$96.12
Edwards Lifesciences Corp Stock (EW) Company Profile
Name
Edwards Lifesciences Corp
Sector
Industry
Phone
(949) 250-2500
Address
ONE EDWARDS WAY, IRVINE, CA
Compare EW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-11-24 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-18-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-24 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jul-29-24 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jul-25-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-25-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-25-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-25-24 | Downgrade | TD Cowen | Buy → Hold |
| Jul-25-24 | Downgrade | Truist | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| May-14-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-07-24 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Nov-28-23 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Sep-26-23 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-08-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-06-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-31-23 | Downgrade | Bernstein | Outperform → Underperform |
| Jan-30-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-06-22 | Downgrade | Stifel | Buy → Hold |
| Oct-28-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-26-22 | Initiated | Mizuho | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-29-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-27-22 | Reiterated | Citigroup | Buy |
| Jan-27-22 | Reiterated | Evercore ISI | Outperform |
| Jan-27-22 | Reiterated | Raymond James | Outperform |
| Jan-27-22 | Reiterated | Stifel | Buy |
| Jan-27-22 | Reiterated | UBS | Neutral |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Dec-06-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-30-21 | Reiterated | Canaccord Genuity | Buy |
| Jul-30-21 | Reiterated | Deutsche Bank | Hold |
| Jul-30-21 | Reiterated | Jefferies | Buy |
| Jul-30-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-30-21 | Reiterated | Oppenheimer | Outperform |
| Jul-30-21 | Reiterated | Stifel | Buy |
| Jul-30-21 | Reiterated | UBS | Neutral |
| Jul-30-21 | Reiterated | Wells Fargo | Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Neutral |
| Apr-05-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-11-20 | Reiterated | Canaccord Genuity | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Underperform |
| Apr-28-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-17-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Neutral |
| Jan-10-20 | Initiated | Oppenheimer | Outperform |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-24-19 | Reiterated | Canaccord Genuity | Buy |
| Sep-23-19 | Initiated | Piper Jaffray | Overweight |
| Jul-24-19 | Reiterated | BofA/Merrill | Buy |
| Mar-18-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Hold |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-16-18 | Initiated | Barclays | Underweight |
| Oct-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-02-18 | Downgrade | Guggenheim | Buy → Neutral |
View All
Edwards Lifesciences Corp Stock (EW) Latest News
Jim Cramer: Is Edwards Lifesciences (EW) Poised for a Comeback? - Insider Monkey
Dominican Republic: A Strategic Destination Attracting Multimillion-Dollar Investments - GlobeNewswire Inc.
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
EDWARDS ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Edwards lifesciences CVP Daniel Lippis sells $185k in stock By Investing.com - Investing.com Australia
Edwards Lifesciences Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Edwards lifesciences CVP Daniel Lippis sells $185k in stock - Investing.com India
Edwards Lifesciences' SWOT analysis: stock outlook amid TAVR challenges and TMTT growth - Investing.com
Daniel J. Lippis Sells 2,500 Shares of Edwards Lifesciences Co. (NYSE:EW) Stock - MarketBeat
Assessing Edwards Lifesciences: Insights From 20 Financial Analysts - Benzinga
Edwards Lifesciences shares upgraded to buy, target lifted on trajectory - Investing.com
Bank of America Upgrades Edwards Lifesciences (NYSE:EW) to "Buy" - MarketBeat
Synovus Financial Corp Sells 13,938 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
TD Private Client Wealth LLC Sells 17,777 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Given Consensus Rating of "Hold" by Analysts - MarketBeat
M&T Bank Corp Reduces Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
EW DEADLINE TODAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Edwards Lifesciences - The Bakersfield Californian
EW DEADLINE TODAY: ROSEN, TOP RANKED GLOBAL COUNSEL, - GlobeNewswire
Faruqi & Faruqi Reminds Edwards Lifesciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024EW - Newsfile
Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now? - Yahoo Finance
Peapack Gladstone Financial Corp Grows Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Zacks Research Issues Optimistic Forecast for EW Earnings - MarketBeat
World Investment Advisors LLC Purchases 68,172 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Teachers Retirement System of The State of Kentucky Has $9.16 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) completed the acquisition of 93% stake in Endotronix Inc. for approximately $800 million - Marketscreener.com
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW) - Business Wire
Virtu Financial LLC Takes Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Shares Bought by Geode Capital Management LLC - MarketBeat
FRIDAY INVESTOR DEADLINE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitEW - AccessWire
Neo Ivy Capital Management Purchases New Shares in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
INVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Edwards Lifesciences Corporation Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before December 13, 2024 to Discuss Your RightsEW - Marketscreener.com
Nomura Asset Management Co. Ltd. Reduces Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Corp. stock rises Wednesday, still underperforms market - MarketWatch
EW INVESTOR ALERT: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - The Eastern Progress Online
EW INVESTOR NOTICE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - The Eastern Progress Online
EW Deadline: Rosen Law Firm Urges Edwards Lifesciences Corporation (NYSE: EW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
EW FRAUD CLASS ACTION: BFA Law Notifies Edwards Lifesciences Investors of the Ongoing Class Action and Encourages You to Contact the Firm before December 13 Deadline - Newsfile
Stifel Financial Corp Boosts Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Stock Position Boosted by Public Employees Retirement System of Ohio - MarketBeat
Kovitz Investment Group Partners LLC Acquires 9,093 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
Edwards bullish on TAVR, long-term growth at investor day - BioWorld Online
Conway Capital Management Inc. Invests $737,000 in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
National Bank of Canada FI Has $20.05 Million Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Class Action Lawsuit Against Edwards Lifesciences Corp. (NYSE:EW) - TipRanks
Is Edwards Lifesciences Stock Underperforming The S&P 500? - Barchart
Edwards Lifesciences CFO Scott Ullem sells $806k in stock By Investing.com - Investing.com South Africa
Edwards Lifesciences exec sells $358,750 in stock By Investing.com - Investing.com Nigeria
Edwards Lifesciences exec sells $358,750 in stock - Investing.com
Edwards Lifesciences Corp Stock (EW) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):